对在存在水分和热量的情况下易发生多态形状转换的API的湿颗粒处理过程选择的评估
Freddy Arce1, Yue Schuman2, John Gawel2
1Drug Product Development, Bristol Myers Squibb, 1 Squibb Drive, New Brunswick, 08901, NJ, USA. freddy.arce@bms.com.
Pharmaceutical research
|February 22, 2024
概括
湿颗粒化可以将活性药物成分 (API) 转化为水合物. 流体床过程最大限度地减少了水合物形成,保留了原始的API形式,使它们成为易受化合物的理想选择.
科学领域:
- 制药技术 制药技术 制药技术
- 固态化学 固态化学
- 工艺工程是过程工程.
背景情况:
- 湿颗粒化 (WG) 是一种多用途的制药工艺.
- 容易产生水合物的API对WG造成挑战,原因是湿度和热量.
- 对于易受水合物影响的API,在WG期间对多态形式转换的数据有限.
研究的目的:
- 评估APIs在湿颗粒过程中水合物形式转换的风险.
- 为了比较高剪切颗粒化 (HSG) 和流体床颗粒化 (FBG) 与托盘干燥 (TD) 和流体床干燥 (FBD).
主要方法:
- 使用了两个模型化合物,fexofenadine化和carbamazepine.
- 粉末X射线衍射监测无水化合物到水合物形式的转化.
- 颗粒的特点是TGA,DSC,BET吸附和分析.
主要成果:
- 液床颗粒和干燥 (FBG+FBD) 保存了原始的API形式.
- 高剪切颗粒与托盘干燥 (HSG+TD) 导致完全转化为水合物形式.
- 随后的液床干燥 (FBD) 导致HSG制备的颗粒部分或完全重新转化为无水形式.
结论:
- 干燥方法对于保存无水API形式至关重要.
- 在保存初始无水形式方面,FBG和FBD工艺优越.
- HSG可能适用于低可溶性API,而FBG+FBD可以最大限度地减少水合物形成.
更多相关视频
相关概念视频
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
308
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
308
Factors Influencing Drug Absorption: Pharmaceutical Parameters
134
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
134
Washing, Drying, and Ignition of Precipitates
913
After filtration, the precipitate is washed to remove coprecipitated impurities and any remaining mother liquor. Colloidal precipitates, such as silver chloride, are washed with an electrolyte (such as dilute nitric acid) to prevent the peptization of the precipitate. In the case of slightly soluble precipitates, the wash solution contains a common ion to reduce solubility. Lead sulfate, which is slightly soluble in water, is washed with dilute sulfuric acid. Similarly, wash solutions may be...
913
Precipitation Processes
447
The experimental conditions in a gravimetric analysis should be optimized to maximize the particle size and purity of the obtained precipitate. Ideally, the concentration of the precipitating reagent should be low with effective stirring to maintain low relative supersaturation for the growth of large crystals. In homogeneous precipitation, the precipitant is slowly generated by a chemical reaction in the solution to avoid local reagent excesses. For example, urea decomposes gradually to...
447
Factors Affecting Dissolution: Particle Size and Effective Surface Area
845
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
845
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
208
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
208


